Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
Clinical trial NCT00275821 · COMPLETED
Trial details
- NCT number
- NCT00275821
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2008-01-01
- Enrollment
- 353
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.